<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">46575273X</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323111838.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170327e19900601xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF01576352</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF01576352</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="4">
   <subfield code="a">The medical treatment of impotence: An update</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Alvaro Morales, Jeremy Heaton]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Summary: Improved understanding of penile physiology has enabled a better therapeutic approach to the treatment of impotence. The injection of vaso-active drugs into the corpora cavernosa is highly effective in a large proportion of patients, but it has major drawbacks. With the exception of hormonal abnormalities in which supplemental or suppressive medication results in a high proportion of cures, the search for effective oral or transcutaneous medication has not yet resulted in dramatic clinical success. Most research has been centered on adrenoceptor antagonists, which have exhibited only limited activity. Other compounds include vaso-dilators such as nitroglycerine, which have shown the ability to enhance tumescence, but their effectiveness remains to be proven. Dopamine receptor agonists are another group of agents of some efficacy that are now under study. The complexity of interactions among the various central and peripheral neurotransmitters suggests that effective therapy for impotence may require a combination of drugs. Renewed efforts in this direction, with proper clinical trials, are justified and hold significant promise.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 1990</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Morales</subfield>
   <subfield code="D">Alvaro</subfield>
   <subfield code="u">Department of Urology and Human Sexuality Center, Queen's University, Kingston General Hospital, K7L 2V7, Kingston, Ontario, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Heaton</subfield>
   <subfield code="D">Jeremy</subfield>
   <subfield code="u">Department of Urology and Human Sexuality Center, Queen's University, Kingston General Hospital, K7L 2V7, Kingston, Ontario, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">World Journal of Urology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">8/2(1990-06-01), 80-83</subfield>
   <subfield code="x">0724-4983</subfield>
   <subfield code="q">8:2&lt;80</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">8</subfield>
   <subfield code="o">345</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF01576352</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF01576352</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Morales</subfield>
   <subfield code="D">Alvaro</subfield>
   <subfield code="u">Department of Urology and Human Sexuality Center, Queen's University, Kingston General Hospital, K7L 2V7, Kingston, Ontario, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Heaton</subfield>
   <subfield code="D">Jeremy</subfield>
   <subfield code="u">Department of Urology and Human Sexuality Center, Queen's University, Kingston General Hospital, K7L 2V7, Kingston, Ontario, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">World Journal of Urology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">8/2(1990-06-01), 80-83</subfield>
   <subfield code="x">0724-4983</subfield>
   <subfield code="q">8:2&lt;80</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">8</subfield>
   <subfield code="o">345</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
